Atlas Trials

Discontinuation Study of Imatinib in Adult CP CML Patients Who Have a Complete Molecular Response to Imatinib

Clinical trial NCT01564836 · UNKNOWN

Trial details

NCT number
NCT01564836
Sponsor
Seoul St. Mary's Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Chronic Myeloid LeukemiaImatinibComplete Molecular Response
Start date
2010-06-01
Primary completion
2015-06-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.